Psoriatic Arthritis
Conference Coverage
Secukinumab showed sustained efficacy in psoriasis
Key clinical point: Psoriasis patients’ initial strong clinical response to the interleukin-17A inhibitor secukinumab is sustained through 52...
Conference Coverage
In psoriasis, is pushing for PASI 90 really worthwhile?
Key clinical point: Psoriasis patients who obtain a PASI 90 response report the quality of life burden imposed by the disease is lifted a full...
News
Biosimilars poised to make biologics more routine
News
Psoriasis severity linked to uncontrolled hypertension
Key clinical point: Patients with moderate to severe psoriasis may benefit from close hypertension management. Major finding: Psoriasis severity...
News
Apremilast improves psoriasis with a side order of weight loss
Key clinical point: Oral apremilast promoted clinically significant weight reduction in addition to clinically meaningful improvement in skin...
Video
VIDEO: Dr. Alan Menter discusses apremilast’s approval for psoriasis
News
High-resolution MRI revealed enthesitis in PsA patients with dactylitis
Key clinical point: High-resolution MRI provided further evidence that enthesitis underlies dactylitis in patients with psoriatic arthritis. Major...
News
Drug combos for psoriatic arthritis upped shingles risk
Key clinical point: Combining TNF-alpha inhibitors with conventional DMARDs more than doubled the risk of shingles in patients with psoriatic...